Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1968 2
1969 1
1972 1
1974 1
1975 1
1978 1
1979 1
1983 1
1984 2
1985 1
1986 3
1988 3
1989 6
1990 8
1991 6
1992 9
1993 4
1994 2
1995 3
1996 2
1997 1
1998 4
1999 2
2000 7
2001 6
2002 14
2003 7
2004 13
2005 14
2006 10
2007 10
2008 5
2009 2
2010 7
2011 21
2012 30
2013 16
2014 12
2015 11
2016 9
2017 6
2018 8
2019 5
2020 8
2021 7
2022 7
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT; JULIET Investigators. Schuster SJ, et al. N Engl J Med. 2019 Jan 3;380(1):45-56. doi: 10.1056/NEJMoa1804980. Epub 2018 Dec 1. N Engl J Med. 2019. PMID: 30501490 Clinical Trial.
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A; Baloxavir Marboxil Investigators Group. Hayden FG, et al. N Engl J Med. 2018 Sep 6;379(10):913-923. doi: 10.1056/NEJMoa1716197. N Engl J Med. 2018. PMID: 30184455 Free article. Clinical Trial.
Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model.
Shide K, Takenaka K, Kitanaka A, Numata A, Kameda T, Yamauchi T, Inagaki A, Mizuno S, Takami A, Ito S, Hagihara M, Usuki K, Maekawa T, Sunami K, Ueda Y, Tsutsui M, Ando M, Komatsu N, Ozawa K, Kurokawa M, Arai S, Mitani K, Akashi K, Shimoda K. Shide K, et al. Among authors: numata a. Blood Cancer J. 2023 Jul 19;13(1):110. doi: 10.1038/s41408-023-00869-9. Blood Cancer J. 2023. PMID: 37463903 Free PMC article. No abstract available.
A case of metastatic renal cell carcinoma to the ovary.
Kato Y, Numata A, Wada N, Iwata T, Saga Y, Hashimoto H, Kakizaki H. Kato Y, et al. Among authors: numata a. Hinyokika Kiyo. 2006 Dec;52(12):923-7. Hinyokika Kiyo. 2006. PMID: 17252974 Free article. Review.
Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial.
Wada N, Mizunaga M, Abe N, Miyauchi K, Kobayashi S, Ohtani M, Tsunekawa R, Nagabuchi M, Morishita S, Ohyama T, Yamaguchi S, Iuchi H, Noda T, Saga Y, Motoya T, Kawakami N, Nishihara M, Numata A, Kakizaki H. Wada N, et al. Among authors: numata a. World J Urol. 2024 Mar 2;42(1):113. doi: 10.1007/s00345-024-04799-4. World J Urol. 2024. PMID: 38431689 Clinical Trial.
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy.
Miyashita K, Tomita N, Taguri M, Suzuki T, Ishiyama Y, Ishii Y, Nakajima Y, Numata A, Hattori Y, Yamamoto W, Miyazaki T, Tachibana T, Takasaki H, Matsumoto K, Hashimoto C, Takemura S, Yamazaki E, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y. Miyashita K, et al. Among authors: numata a. Leuk Res. 2015 Aug 29:S0145-2126(15)30368-4. doi: 10.1016/j.leukres.2015.08.016. Online ahead of print. Leuk Res. 2015. PMID: 26350140
275 results